ArticleHuman vaccines & immunotherapeutics2019

Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live.

Desmond Curran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.